Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STOK | AMGN | VRTX | REGN | GSK |
| Company | Stoke Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 16.12 | 307.80 | 475.26 | 993.44 | 42.39 |
| High | 16.69 | 310.31 | 484.45 | 1,015.00 | 42.44 |
| Low | 15.67 | 306.40 | 474.16 | 989.77 | 41.86 |
| Last | 16.41 | 307.38 | 483.04 | 1,005.87 | 41.97 |
| Change | +0.51 | +0.01 | +8.09 | +12.58 | +0.62 |
| % Change | +3.21% | unch | +1.70% | +1.27% | +1.50% |
| Volume | 672,500 | 1,748,500 | 1,196,700 | 385,500 | 7,230,400 |
| 20-Day Average Volume | 784,010 | 2,413,000 | 1,221,495 | 389,510 | 4,332,890 |
| Previous Close | 15.90 | 307.37 | 474.95 | 993.29 | 41.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.10 | 308.66 | 445.01 | 979.83 | 44.34 |
| 20-Day Raw Stochastic | 95.07% | 45.82% | 98.05% | 85.48% | 26.96% |
| 20-Day Relative Strength | 65.91% | 57.48% | 75.30% | 63.66% | 44.32% |
| Weighted Alpha | +34.83 | +36.13 | +49.42 | +35.26 | +20.01 |
| Today's Opinion | 100% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 24% Buy | 8% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.17% since 05/29/24 | +3.71% since 05/29/24 | +9.50% since 05/29/24 | +4.07% since 05/29/24 | -5.22% since 05/29/24 |
| Low | 13.67 on 05/30/24 | 295.49 on 05/30/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 16.69 on 06/05/24 | 311.48 on 06/03/24 | 484.45 on 06/05/24 | 1,015.00 on 06/05/24 | 45.01 on 05/31/24 |
| 1-Month | |||||
| %Chg | +36.52% since 05/03/24 | -1.26% since 05/03/24 | +20.43% since 05/03/24 | +5.11% since 05/03/24 | -3.52% since 05/03/24 |
| Low | 11.01 on 05/10/24 | 295.49 on 05/30/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 40.51 on 06/03/24 |
| High | 16.69 on 06/05/24 | 321.44 on 05/15/24 | 484.45 on 06/05/24 | 1,015.00 on 06/05/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +130.15% since 03/05/24 | +11.11% since 03/05/24 | +16.27% since 03/05/24 | +4.21% since 03/05/24 | -1.48% since 03/05/24 |
| Low | 5.60 on 03/20/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 16.69 on 06/05/24 | 322.60 on 05/03/24 | 484.45 on 06/05/24 | 1,015.00 on 06/05/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +297.34% since 12/05/23 | +13.48% since 12/05/23 | +36.39% since 12/05/23 | +22.53% since 12/05/23 | +15.52% since 12/05/23 |
| Low | 4.09 on 02/13/24 | 260.68 on 04/19/24 | 348.46 on 12/08/23 | 824.22 on 12/06/23 | 35.81 on 12/07/23 |
| High | 16.69 on 06/05/24 | 329.72 on 02/05/24 | 484.45 on 06/05/24 | 1,015.00 on 06/05/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 828,708 | 164,884,016 | 122,562,280 | 109,446,640 | 85,695,392 |
| Shares Outstanding, K | 52,120 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 8,780,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -104,700,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 4,220,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -26,370,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.88 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 05/06/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 31.22 | 26.66 | 10.12 |